Evidence map›Paper›PMID 33467150›Full record

ReviewNutrients2021

Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications.

Ana Checa-Ros, Antonio Jeréz-Calero, Antonio Molina-Carballo, Cristina Campoy, Antonio Muñoz-Hoyos

Registry-linked trialAbstract readReview
In one paragraph

Review in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07665658 (Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children), which is not on this map. Cited by 81 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07665658 narecruitingnot on this mapstarted 2026, after this paper: background citation

Effectiveness of Neuroplasticity-Targeted Supplements on Neuroinflammatory Markers, ADHD Symptom Severity, and Clinical Scores in Children: A Randomized Controlled Trial

TypeinterventionalSponsorKhyber Medical University PeshawarRan2026 to 2026Enrolled68ConditionsAttention Deficit Hyperactivity DisorderArmsInulin, Probiotic, Omega-3 Fatty Acids, Thiamine, Placebo
3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Add-OnNutrients · 2024
    Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Gut Microbiome and ADHD: A Narrative Review of Clinical Evidence and Practice Implications.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana Checa-RosSchool of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK.ORCID 0000-0001-8958-6711
Antonio Jeréz-CaleroDepartment of Pediatrics, San Cecilio University Hospital, 18016 Granada, Spain.
Antonio Molina-CarballoDepartment of Pediatrics, School of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0002-2955-5064
Cristina CampoyDepartment of Pediatrics, School of Medicine, University of Granada, 18016 Granada, Spain.ORCID 0000-0002-9860-6785
Antonio Muñoz-HoyosDepartment of Pediatrics, School of Medicine, University of Granada, 18016 Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies suggest that the bidirectional relationship existent between the gut microbiome (GM) and the central nervous system (CNS), or so-called the microbiome-gut-brain axis (MGBA), is involved in diverse neuropsychiatric diseases in children and adults. In pediatric age, most studies have focused on patients with autism. However, evidence of the role played by the MGBA in attention deficit/hyperactivity disorder (ADHD), the most common neurodevelopmental disorder in childhood, is still scanty and heterogeneous. This review aims to provide the current evidence on the functioning of the MGBA in pediatric patients with ADHD and the specific role of omega-3 polyunsaturated fatty acids (ω-3 PUFAs) in this interaction, as well as the potential of the GM as a therapeutic target for ADHD. We will explore: (1) the diverse communication pathways between the GM and the CNS; (2) changes in the GM composition in children and adolescents with ADHD and association with ADHD pathophysiology; (3) influence of the GM on the ω-3 PUFA imbalance characteristically found in ADHD; (4) interaction between the GM and circadian rhythm regulation, as sleep disorders are frequently comorbid with ADHD; (5) finally, we will evaluate the most recent studies on the use of probiotics in pediatric patients with ADHD.

Indexed as

Dietary SupplementsAdolescentAdultAnimalsAttention Deficit Disorder with HyperactivityBrainChildFatty Acids, Omega-3FemaleGastrointestinal MicrobiomeHumansMaleProbioticsFatty Acids, Omega-3ADHDcircadian rhythmfatty acidsgastrointestinal microbiomeomega-3probiotics

Identifiers

PMID33467150
PMCPMC7830868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.